Ilex Capital Partners (UK) LLP
Position in TMO — Thermo Fisher Scientific Inc.
CIK 1985486
London, X0
Position in TMO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$45,227,641
-$11,755,231 QoQ
Shares Held
92,014
-16.0% QoQ
Ownership
0.025%
of shares outstanding
% of Portfolio
1.11%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
4 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Ilex Capital Partners (UK) LLP holds $338,382,479 across 5 Diagnostics & Research names. TMO ranks #4 (13.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | A |
Agilent Technologies, Inc.
|
1,206,449 | $137,511,057 | |
| 2 | ILMN |
Illumina, Inc.
|
605,343 | $74,614,578 | |
| 3 | IQV |
Iqvia Holdings Inc.
|
276,395 | $47,136,403 | |
| 4 | TMO |
Thermo Fisher Scientific Inc.
This page
|
92,014 | $45,227,641 | |
| 5 | CRL |
Charles River Laboratories International, Inc.
|
196,480 | $33,892,800 |
All Filings in TMO
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $45,227,641 | 92,014 | Shares | Sole | 2026-05-15 | |
| 2024-12-31 | $56,982,872 | 109,534 | Shares | Sole | 2025-02-14 | |
| 2024-06-30 | $80,595,879 | 145,743 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $6,585,109 | 11,330 | Shares | Sole | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||